Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology

Pulmonary delivery is a promising alternative for the oral treatment of pulmonary aspergillosis. This study aimed to develop continuous and scalable itraconazole PEGylated nano-lipid carriers (ITZ-PEG-NLC) for inhalation delivery. The feasibility of preparing NLCs utilizing hot-melt extrusion (HME)...

Full description

Bibliographic Details
Published in:International Journal of Pharmaceutics: X
Main Authors: Gauri Shadambikar, Sushrut Marathe, Nan Ji, Mashan Almutairi, Suresh Bandari, Feng Zhang, Mahavir Chougule, Michael Repka
Format: Article in Journal/Newspaper
Language:English
Published: Elsevier 2021
Subjects:
Online Access:https://doi.org/10.1016/j.ijpx.2021.100074
https://doaj.org/article/976cb0ee04e84701b828b8aaae3ada87
id ftdoajarticles:oai:doaj.org/article:976cb0ee04e84701b828b8aaae3ada87
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:976cb0ee04e84701b828b8aaae3ada87 2023-05-15T18:12:40+02:00 Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology Gauri Shadambikar Sushrut Marathe Nan Ji Mashan Almutairi Suresh Bandari Feng Zhang Mahavir Chougule Michael Repka 2021-12-01T00:00:00Z https://doi.org/10.1016/j.ijpx.2021.100074 https://doaj.org/article/976cb0ee04e84701b828b8aaae3ada87 EN eng Elsevier http://www.sciencedirect.com/science/article/pii/S2590156721000037 https://doaj.org/toc/2590-1567 2590-1567 doi:10.1016/j.ijpx.2021.100074 https://doaj.org/article/976cb0ee04e84701b828b8aaae3ada87 International Journal of Pharmaceutics: X, Vol 3, Iss , Pp 100074- (2021) Itraconazole PEGylation Hot-melt extrusion Pulmonary drug delivery Inhalation Nanostructured lipid carriers Pharmacy and materia medica RS1-441 article 2021 ftdoajarticles https://doi.org/10.1016/j.ijpx.2021.100074 2022-12-31T07:46:11Z Pulmonary delivery is a promising alternative for the oral treatment of pulmonary aspergillosis. This study aimed to develop continuous and scalable itraconazole PEGylated nano-lipid carriers (ITZ-PEG-NLC) for inhalation delivery. The feasibility of preparing NLCs utilizing hot-melt extrusion (HME) coupled with probe sonication was investigated. The process parameters for HME and sonication were varied to optimize the formulation. ITZ-PEG-NLC (particle size, 101.20 ± 1.69 nm; polydispersity index, 0.26 ± 0.01) was successfully formulated. The drug entrapment efficiency of ITZ-PEG-NLC was 97.28 ± 0.50%. Transmission electron microscopy was used to characterize the shape of the particles. The developed formulations were evaluated for their aerodynamic properties for pulmonary delivery. The lung deposition of ITZ-PEG-NLC was determined using an Anderson Cascade Impactor and Philips Respironics Sami the Seal Nebulizer Compressor. In vitro cytotoxicity studies were performed using A549 cells. A burst-release pattern was observed in ITZ-PEG-NLC with a drug release of 41.74 ± 1.49% in 60 min. The in vitro aerosolization of the ITZ-PEG-NLC formulation showed a mass median aerodynamic diameter of 3.51 ± 0.28 μm and a geometric standard deviation of 2.44 ± 0.49. These findings indicate that HME technology could be used for the production of continuous scalable ITZ-PEG-NLC. Article in Journal/Newspaper sami Directory of Open Access Journals: DOAJ Articles International Journal of Pharmaceutics: X 3 100074
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic Itraconazole
PEGylation
Hot-melt extrusion
Pulmonary drug delivery
Inhalation
Nanostructured lipid carriers
Pharmacy and materia medica
RS1-441
spellingShingle Itraconazole
PEGylation
Hot-melt extrusion
Pulmonary drug delivery
Inhalation
Nanostructured lipid carriers
Pharmacy and materia medica
RS1-441
Gauri Shadambikar
Sushrut Marathe
Nan Ji
Mashan Almutairi
Suresh Bandari
Feng Zhang
Mahavir Chougule
Michael Repka
Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology
topic_facet Itraconazole
PEGylation
Hot-melt extrusion
Pulmonary drug delivery
Inhalation
Nanostructured lipid carriers
Pharmacy and materia medica
RS1-441
description Pulmonary delivery is a promising alternative for the oral treatment of pulmonary aspergillosis. This study aimed to develop continuous and scalable itraconazole PEGylated nano-lipid carriers (ITZ-PEG-NLC) for inhalation delivery. The feasibility of preparing NLCs utilizing hot-melt extrusion (HME) coupled with probe sonication was investigated. The process parameters for HME and sonication were varied to optimize the formulation. ITZ-PEG-NLC (particle size, 101.20 ± 1.69 nm; polydispersity index, 0.26 ± 0.01) was successfully formulated. The drug entrapment efficiency of ITZ-PEG-NLC was 97.28 ± 0.50%. Transmission electron microscopy was used to characterize the shape of the particles. The developed formulations were evaluated for their aerodynamic properties for pulmonary delivery. The lung deposition of ITZ-PEG-NLC was determined using an Anderson Cascade Impactor and Philips Respironics Sami the Seal Nebulizer Compressor. In vitro cytotoxicity studies were performed using A549 cells. A burst-release pattern was observed in ITZ-PEG-NLC with a drug release of 41.74 ± 1.49% in 60 min. The in vitro aerosolization of the ITZ-PEG-NLC formulation showed a mass median aerodynamic diameter of 3.51 ± 0.28 μm and a geometric standard deviation of 2.44 ± 0.49. These findings indicate that HME technology could be used for the production of continuous scalable ITZ-PEG-NLC.
format Article in Journal/Newspaper
author Gauri Shadambikar
Sushrut Marathe
Nan Ji
Mashan Almutairi
Suresh Bandari
Feng Zhang
Mahavir Chougule
Michael Repka
author_facet Gauri Shadambikar
Sushrut Marathe
Nan Ji
Mashan Almutairi
Suresh Bandari
Feng Zhang
Mahavir Chougule
Michael Repka
author_sort Gauri Shadambikar
title Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology
title_short Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology
title_full Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology
title_fullStr Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology
title_full_unstemmed Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology
title_sort formulation development of itraconazole pegylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology
publisher Elsevier
publishDate 2021
url https://doi.org/10.1016/j.ijpx.2021.100074
https://doaj.org/article/976cb0ee04e84701b828b8aaae3ada87
genre sami
genre_facet sami
op_source International Journal of Pharmaceutics: X, Vol 3, Iss , Pp 100074- (2021)
op_relation http://www.sciencedirect.com/science/article/pii/S2590156721000037
https://doaj.org/toc/2590-1567
2590-1567
doi:10.1016/j.ijpx.2021.100074
https://doaj.org/article/976cb0ee04e84701b828b8aaae3ada87
op_doi https://doi.org/10.1016/j.ijpx.2021.100074
container_title International Journal of Pharmaceutics: X
container_volume 3
container_start_page 100074
_version_ 1766185170340151296